Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    Adenovirus/PSA Vaccine AND Prostate Cancer
Show Display Options
Rank Status Study
1 Active, not recruiting Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21
Condition: Recurrent Prostate Cancer
Intervention: Biological: Adenovirus/PSA Vaccine
2 Active, not recruiting Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Biological: ADENOVIRUS/PSA VACCINE
3 Recruiting VAccination in Prostate caNCEr (VANCE)
Condition: Prostate Cancer
Interventions: Biological: ChAdOx1.5T4;   Biological: MVA.5T4;   Drug: Cyclophosphamide

Indicates status has not been verified in more than two years